• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Amphastar Pharmaceuticals, Inc. - Common Stock (NQ:AMPH)

    25.50 +0.84 (+3.41%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 552,328
    Open 24.36
    Bid (Size) 23.50 (1)
    Ask (Size) 26.00 (1)
    Prev. Close 24.66
    Today's Range 24.24 - 25.60
    52wk Range 20.39 - 53.95
    Shares Outstanding 48,081,433
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    1 of Wall Street’s Favorite Stock to Target This Week and 2 That Underwhelm
    Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
    Via StockStory
    Topics Economy
    Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
    Via ACCESS Newswire

    Performance

    YTD
    -29.9%
    -29.9%
    1 Month
    -4.3%
    -4.3%
    3 Month
    +21.7%
    +21.7%
    6 Month
    +6.8%
    +6.8%
    1 Year
    -49.8%
    -49.8%

    More News

    Read More
    2 Reasons AMPH is Risky and 1 Stock to Buy Instead
    Via StockStory
    Topics Economy Government Stocks
    Demystifying Amphastar Pharma: Insights From 4 Analyst Reviews
    Via Benzinga
    Earnings Scheduled For August 7, 2025
    Via Benzinga
    Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know
    Via StockStory
    Topics Economy Government World Trade
    Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs
    Via Benzinga
    Topics Government World Trade
    3 Stocks Under $50 We’re Skeptical Of
    Via StockStory
    3 Value Stocks with Warning Signs
    Via StockStory
    Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): A Value Investor's Opportunity
    Via Chartmill
    3 Low-Volatility Stocks with Open Questions
    Via StockStory
    3 Small-Cap Stocks That Concern Us
    Via StockStory
    Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) Presents a Compelling Value Investment Case
    Via Chartmill
    A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    3 Profitable Stocks We Steer Clear Of
    Via StockStory
    Amphastar Pharmaceuticals to Present at the 2025 Wells Fargo Healthcare Conference
    Via ACCESS Newswire
    Amphastar Pharmaceuticals Inc (NASDAQ:AMPH): A Value Stock with Strong Fundamentals and Undervalued Potential
    Via Chartmill
    Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Bonds Economy Lawsuit
    Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
    Via Benzinga
    Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
    Via ACCESS Newswire
    Amphastar Announces FDA Approval for Iron Sucrose Injection, USP
    Via ACCESS Newswire
    Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q2 Sales Targets, But Stock Soars 6%
    Via StockStory
    Amphastar (AMPH) Q2 2025 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings Supply Chain
    Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2025
    Via ACCESS Newswire
    1 of Wall Street’s Favorite Stock to Target This Week and 2 We Find Risky
    Via StockStory

    Frequently Asked Questions

    Is Amphastar Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Amphastar Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Amphastar Pharmaceuticals, Inc. - Common Stock trade on?
    Amphastar Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Amphastar Pharmaceuticals, Inc. - Common Stock is AMPH on the Nasdaq Stock Market
    What is the current price of Amphastar Pharmaceuticals, Inc. - Common Stock?
    The current price of Amphastar Pharmaceuticals, Inc. - Common Stock is 25.50
    When was Amphastar Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Amphastar Pharmaceuticals, Inc. - Common Stock was at 10/31/25 04:00 PM ET
    What is the market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Amphastar Pharmaceuticals, Inc. - Common Stock is 1.23B
    How many shares of Amphastar Pharmaceuticals, Inc. - Common Stock are outstanding?
    Amphastar Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.